{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.7643.3.1051",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2019-01-08T01:00:08.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Oncology Nursing Society Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2022-12-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2019-01-08"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.3.1051",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.7643.3.1051"
    }
  ],
  "version" : "20190108",
  "name" : "TyrosineKinaseInhibitorsForChronicMyeloidLeukemia",
  "title" : "Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia",
  "status" : "active",
  "experimental" : false,
  "date" : "2019-01-08T01:00:08-05:00",
  "publisher" : "Oncology Nursing Society Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set contains RxNORM codes associated with tyrosine kinase inhibitors (TKIs) commonly used to treat patients with chronic myeloid leukemia.),(Data Element Scope: This would use the Medication QDM category.),(Inclusion Criteria: The following generic, prescribable TKIs are included in this value set: bosutinib, dasatinib, imatinib, nilotinib, ponatinib.),(Exclusion Criteria: TKIs not listed above are excluded from this value set, including brand name drugs or brand name drug packs.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.1049"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:143ffb9f-d778-41b4-a95a-e00ecd712af7",
    "timestamp" : "2023-11-26T21:53:59-05:00",
    "total" : 17,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1045402",
        "display" : "dasatinib 140 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1045406",
        "display" : "dasatinib 80 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1307624",
        "display" : "bosutinib 100 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1307633",
        "display" : "bosutinib 500 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1364352",
        "display" : "ponatinib 15 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1364360",
        "display" : "ponatinib 45 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1726637",
        "display" : "ponatinib 30 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1987732",
        "display" : "bosutinib 400 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "2002717",
        "display" : "nilotinib 50 MG Oral Capsule"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "403878",
        "display" : "imatinib 100 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "403879",
        "display" : "imatinib 400 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "643105",
        "display" : "dasatinib 20 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "643107",
        "display" : "dasatinib 50 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "643109",
        "display" : "dasatinib 70 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "746606",
        "display" : "nilotinib 200 MG Oral Capsule"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "799047",
        "display" : "dasatinib 100 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "997653",
        "display" : "nilotinib 150 MG Oral Capsule"
      }
    ]
  }
}
